These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 2542577)

  • 1. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.
    Sugden B; Warren N
    J Virol; 1989 Jun; 63(6):2644-9. PubMed ID: 2542577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication.
    Hearing J; Mülhaupt Y; Harper S
    J Virol; 1992 Feb; 66(2):694-705. PubMed ID: 1309908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus.
    Frappier L; O'Donnell M
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10875-9. PubMed ID: 1660154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Puglielli MT; Woisetschlaeger M; Speck SH
    J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
    Lupton S; Levine AJ
    Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.
    Sample J; Henson EB; Sample C
    J Virol; 1992 Aug; 66(8):4654-61. PubMed ID: 1321268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
    Harrison S; Fisenne K; Hearing J
    J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Reisman D; Sugden B
    Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
    Wang F; Kikutani H; Tsang SF; Kishimoto T; Kieff E
    J Virol; 1991 Aug; 65(8):4101-6. PubMed ID: 1649318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1.
    Su W; Middleton T; Sugden B; Echols H
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10870-4. PubMed ID: 1660153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites.
    Jones CH; Hayward SD; Rawlins DR
    J Virol; 1989 Jan; 63(1):101-10. PubMed ID: 2535719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Yates JL; Warren N; Sugden B
    Nature; 1985 Feb 28-Mar 6; 313(6005):812-5. PubMed ID: 2983224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-stranded structures are present within plasmids containing the Epstein-Barr virus latent origin of replication.
    Orlowski R; Miller G
    J Virol; 1991 Feb; 65(2):677-86. PubMed ID: 1846191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.
    Rooney CM; Brimmell M; Buschle M; Allan G; Farrell PJ; Kolman JL
    J Virol; 1992 Jan; 66(1):496-504. PubMed ID: 1309259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.